WCRF Researchers Contribute to National Library of Medicine Article on Vaping and Smoking Cessation

We’re proud to share that Dr. John Micha and Bram Goldstein, PhD of the Women’s Cancer Research Foundation co-authored a recently published article in the National Library of Medicine. The article critically examines the health risks, benefits, and efficacy of electronic cigarettes (e-cigarettes) as a smoking cessation tool. This contribution underscores WCRF’s leadership in advancing public health discourse around cancer prevention and behavioral risk factors.

The full article, titled “Vaping and Smoking Cessation,” is now available in the Journal of Addictive Diseases via the National Library of Medicine here.

The Debate on E-Cigarettes: Are They Really Helping Smokers Quit?

What the Study Explored

The research team conducted an extensive review of existing studies on vaping, focusing on e-cigarettes as a potential alternative for individuals trying to quit traditional tobacco smoking. While marketed as a safer or less harmful option, e-cigarettes are increasingly being adopted by young adults and teens raising concern about long-term health implications and nicotine addiction.

Key Findings

• Limited Evidence for Cessation: The study found inconclusive evidence supporting e-cigarettes as an effective smoking cessation tool.

• Potential Health Risks: E-cigarettes were associated with carcinogenic potential and cardiopulmonary complications, with inconsistent safety data across different studies.

• Risk for Vulnerable Populations: Teens and young adults may be especially at risk for dependency due to marketing tactics and ease of access.

Clinical Recommendation

Until more definitive, long-term evidence supports their efficacy and safety, the study advises that e-cigarettes should not be recommended as a primary cessation method. Public health strategies must remain focused on well-established interventions while continuing to research emerging trends like vaping.

How This Aligns With WCRF’s Mission

At the Women’s Cancer Research Foundation, we believe prevention is just as powerful as treatment. Addressing modifiable lifestyle risks like smoking and now vaping is a key step in reducing cancer diagnoses across the population. By contributing to this body of research, our team continues to influence national health strategies that protect and inform the public.

Frequently Asked Questions

Are e-cigarettes safer than regular cigarettes?

While e-cigarettes may contain fewer harmful chemicals than traditional cigarettes, they are not risk-free. Studies show they can still cause inflammation, lung damage, and nicotine addiction. Especially with long-term use.

Can vaping help me quit smoking?

There is no conclusive evidence that vaping is more effective than FDA-approved smoking cessation methods like nicotine patches or medications. The results are mixed, and health experts caution against relying on e-cigarettes as a quitting strategy.

Is vaping harmful for teens and young adults?

Yes. Adolescents are more vulnerable to nicotine addiction and may face long-term health consequences. E-cigarettes can also serve as a gateway to traditional smoking.

What does WCRF recommend for smoking cessation?

We recommend evidence-based programs supported by medical guidance. If you're looking to quit smoking, consult a healthcare provider for personalized support and access to effective tools.

About Women’s Cancer Research Foundation:

The Women’s Cancer Research Foundation (WCRF) is one of the most active research organizations in the nation. We are dedicated to studying and evaluating novel treatments for women afflicted with breast, ovarian, endometrial, and cervical cancers. The WCRF persistently endeavors to make a difference in women’s lives by offering them hope, strength, and progress.